SCHEDULE 13G/A
0001193125-24-090860
0001863769
XXXXXXXX
LIVE
2
Common stock, par value $0.0001 per share
07/23/2025
0001783032 Elevation Oncology, Inc. 28623U101
101 Federal Street, Suite 1900
Boston
MA
02110
Rule 13d-1(c)
Frazier Life Sciences Public Fund, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP, L.L.C.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
Frazier Life Sciences Public Overage Fund, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP Overage, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP Overage, L.L.C.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
Frazier Life Sciences X, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS X, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS X, L.L.C.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
Frazier Life Sciences XI, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS XI, L.P.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS XI, L.L.C.
b
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
James N. Topper
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Patrick J. Heron
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Albert Cha
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
James Brush
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Daniel Estes
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Elevation Oncology, Inc.
101 Federal Street, Suite 1900, Boston, MA, 02110.
The entities and persons filing this statement (collectively, the "Reporting Persons") are:
Frazier Life Sciences Public Fund, L.P. ("FLSPF")
FHMLSP, L.P.
FHMLSP, L.L.C.
Frazier Life Sciences Public Overage Fund, L.P. ("FLSPOF")
FHMLSP Overage, L.P.
FHMLSP Overage, L.L.C.
Frazier Life Sciences XI, L.P. ("FLS XI")
FHMLS XI, L.P.
FHMLS XI, L.L.C.
Frazier Life Sciences X, L.P. ("FLS X")
FHMLS X, L.P.
FHMLS X, L.L.C.
James N. Topper ("Topper")
Patrick J. Heron ("Heron")
Albert Cha ("Cha")
James Brush ("Brush")
Daniel Estes ("Estes" and together with Topper, Heron, Cha and Brush, the "Members") The address and principal business office of the Reporting Persons is:
c/o Frazier Life Sciences Management, L.P.
1001 Page Mill Rd, Building 4, Suite B
Palo Alto, CA 94304 The information contained in row 4 of each Reporting Person's cover page to this Statement is incorporated by reference.
Y
The information contained in row 9 of each Reporting Person's cover page to this Statement is incorporated by reference.
Except as specifically stated herein, the filing of this Statement shall not be construed as an admission that any Reporting Person or any of the foregoing is, for the purposes of Section 13(d) and/or Section 13(g) of the Act or otherwise, the beneficial owner of any securities covered by this Statement or a member of a "group" with any other person. The information contained in row 11 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 5 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 6 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 7 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 8 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Exhibit 99.1 Joint Filing Agreement, dated as of July 15, 2024, incorporated by reference into this Statement.
Frazier Life Sciences Public Fund, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
08/14/2025
FHMLSP, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
08/14/2025
FHMLSP, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C.
08/14/2025
Frazier Life Sciences Public Overage Fund, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P.
08/14/2025
FHMLSP Overage, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P.
08/14/2025
FHMLSP Overage, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C.
08/14/2025
Frazier Life Sciences X, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
08/14/2025
FHMLS X, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
08/14/2025
FHMLS X, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C.
08/14/2025
Frazier Life Sciences XI, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
08/14/2025
FHMLS XI, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
08/14/2025
FHMLS XI, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
08/14/2025
James N. Topper
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
08/14/2025
Patrick J. Heron
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
08/14/2025
Albert Cha
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
08/14/2025
James Brush
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
08/14/2025
Daniel Estes
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022
08/14/2025